Combining oxymatrine and a p38 signaling pathway inhibitor (SB203580) caused significantly inhibition of HCC cell invasion via reducing MMP-2/-9, which further revealed the role of p38 signaling pathway in the anti-metastatic effect of oxymatrine. The gene discussed is MMP2; the disease is hepatocellular carcinoma.